Back to Search
Start Over
LBA12 Efficacy and safety of IBI351 (GFH925), a selective KRASG12C inhibitor, monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Initial results from a registrational phase II study.
- Source :
-
Annals of Oncology . 2023 Supplement 4, Vol. 34, pS1662-S1662. 1p. - Publication Year :
- 2023
- Subjects :
- *NON-small-cell lung carcinoma
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 34
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 173758464
- Full Text :
- https://doi.org/10.1016/j.annonc.2023.10.584